Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2001

View Archived Issues

GT-160-246 as a promising approach to C. difficile colitis

Phase IIb clinical trial of ATL-1251 to begin in U.K. in IBS patients

Proof of principle demonstrated in phase II studies for novel cardiology candidate therapeutic

Bayer and GeneData extend successful genomics-based antibiotic discovery collaboration

Muscarinic M3 antagonist YM-905 studied in experimental models of IBS symptoms

Castor oil component demonstrates both pro- and antiinflammatory properties

AnorMED makes significant strides in development programs

AJ-2615, a dual calcium antagonist and alpha1-adrenoceptor blocker: implications for CABG patients

Solvay identifies new atypical antipsychotic candidate

Long-term AICAR has beneficial metabolic and cardiovascular effects in rat IRS model

Methods and compositions for inflammatory diseases disclosed by GSK

Synthesis and use of new macrolides described by Pfizer

Anti-TNF agents in development at Sanofi-Synthelabo

Inhibitors of cysteine proteases of the ICE/ced-3 family identified by Idun

Shionogi patents potent new antitumor agents useful against solid tumors

New ADIR compounds useful for improving endothelial dysfunction

Oxazolidinone antibacterial agents discovered by Abbott

Clinical development update presented by Novuspharma for second quarter

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...